63,113 Shares in DaVita Inc. (NYSE:DVA) Bought by International Assets Investment Management LLC

International Assets Investment Management LLC purchased a new position in DaVita Inc. (NYSE:DVA) in the third quarter, Holdings Channel.com reports. The fund purchased 63,113 shares of the company’s stock, valued at approximately $10,346,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Harvard Management Co. Inc. bought a new position in DaVita in the second quarter worth $55,115,000. Lazard Asset Management LLC raised its holdings in DaVita by 147.3% in the first quarter. Lazard Asset Management LLC now owns 256,872 shares of the company’s stock worth $35,460,000 after purchasing an additional 153,008 shares in the last quarter. Jupiter Asset Management Ltd. raised its holdings in DaVita by 146.7% in the first quarter. Jupiter Asset Management Ltd. now owns 187,177 shares of the company’s stock worth $25,840,000 after purchasing an additional 111,311 shares in the last quarter. Point72 Asset Management L.P. bought a new position in DaVita in the second quarter worth $9,615,000. Finally, Hennessy Advisors Inc. bought a new position in DaVita in the second quarter worth $8,439,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insiders Place Their Bets

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Michael David Staffieri sold 9,539 shares of the firm’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $150.03, for a total value of $1,431,136.17. Following the completion of the transaction, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 173,482 shares of company stock valued at $27,387,069. Insiders own 2.00% of the company’s stock.

DaVita Price Performance

NYSE DVA opened at $141.16 on Thursday. DaVita Inc. has a one year low of $76.17 and a one year high of $168.50. The stock has a 50-day moving average of $158.21 and a 200 day moving average of $146.02. The company has a market capitalization of $11.84 billion, a price-to-earnings ratio of 15.03, a PEG ratio of 0.90 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business posted $2.85 earnings per share. DaVita’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, sell-side analysts forecast that DaVita Inc. will post 9.99 EPS for the current year.

Analysts Set New Price Targets

DVA has been the subject of a number of research reports. TD Cowen increased their price objective on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Bank of America raised their price target on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. UBS Group raised their price target on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Finally, Truist Financial raised their price target on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $159.00.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.